skip to Main Content
Research
People
Publications
News
Contact
Photo Gallery
Search
Search
Submit
×
Close search
Publications
Merkel Cell Carcinoma: An Unusually Immunogenic Cancer Proves Ripe for Immune Therapy.
Vandeven N, Nghiem P.
J Oncol Pract.
2016 Jul;12(7):649-50.
PMID: 27407162
View on PubMed
-
View PDF
J Oncol Pract.
2016 Jul;12(7):649-50.
Related Items
Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck
Clinical Benefit of Baseline Imaging in Merkel Cell Carcinoma: Analysis of 584 Patients
The 6-4 Photoproduct Is the Trigger of UV-induced Replication Blockage and ATR Activation
previous post:
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
next post:
Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
Back To Top
